P. ex rel. State Dept. of State Hospitals v. S.F. CA2/6 ( 2022 )


Menu:
  • Filed 7/26/22 P. ex rel. State Dept. of State Hospitals v. S.F. CA2/6
    NOT TO BE PUBLISHED IN THE OFFICIAL REPORTS
    California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions
    not certified for publication or ordered published, except as specified by rule 8.1115(b). This opinion
    has not been certified for publication or ordered published for purposes of rule 8.1115.
    IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA
    SECOND APPELLATE DISTRICT
    DIVISION SIX
    THE PEOPLE ex rel. STATE                                     2d Crim. No. B317820
    DEPARTMENT OF STATE                                        (Super. Ct. No. 21MH-0003)
    HOSPITALS,                                                 (San Luis Obispo County)
    Plaintiff and Respondent,
    v.
    S.F.,
    Defendant and Appellant.
    S.F. appeals from the trial court’s order compelling his
    involuntary medication with antipsychotic drugs. S.F. contends
    the medication order should be vacated because there was
    insufficient evidence that he lacks the capacity to make informed
    decisions about his medical treatment. We affirm.
    FACTUAL AND PROCEDURAL HISTORY
    S.F. was committed to Atascadero State Hospital in June
    2020 as an offender with a mental health disorder (OMHD).1
    (See Pen. Code, § 2962 et seq.) In January 2021, the Department
    of State Hospitals petitioned the trial court to order S.F. to
    undergo involuntary treatment with antipsychotic medications
    pursuant to In re Qawi (2004) 
    32 Cal.4th 1
     (Qawi) and Welfare
    and Institutions Code section 5300 et seq. The court granted the
    petition, and ordered that S.F. be involuntarily medicated for up
    to one year.
    In January 2022, the Department petitioned the trial court
    to renew the order compelling S.F.’s involuntary medication. The
    petition alleged that S.F. has been diagnosed with schizoaffective
    disorder, bipolar type, and suffers from auditory hallucinations,
    persecutory delusions, and disorganized behavior and thought
    processes, among other allegations. He does not believe he needs
    treatment because he does not have a mental disorder and does
    not benefit from antipsychotic medication.
    Dr. David Fennell testified as an expert at the hearing on
    the Department’s renewal petition. He said that S.F. was
    diagnosed with schizoaffective disorder in his late teens or early
    20’s. The disorder primarily manifests itself as auditory
    hallucinations, which S.F. describes as a “natural ability to hear
    voices” or telepathy.
    S.F. exhibits irritation, agitation, and paranoia, including
    the belief that others wish to do him harm. He has a history of
    noncompliance with his medication regimen and a history of
    becoming angry and irritable to the point of getting into physical
    1 OMHDs   were previously termed “mentally disordered
    offenders” or “MDOs.” (Pen. Code, former § 2962, subd. (d)(3).)
    2
    and verbal confrontations. His mental disorders are currently
    being treated with three medications.
    Dr. Fennell said that S.F. does not believe that he has a
    mental disorder and believes that he is being wrongly medicated.
    When S.F. does not take his medications he experiences more
    severe hallucinations and paranoia and has less ability to keep
    his temper. When he complies with his medication regimen he
    hears voices less often; is less guarded, paranoid, and distracted;
    and does not lose his temper as easily.
    On cross-examination, Dr. Fennell testified that S.F.’s
    concerns about the side effects of his medications are legitimate.
    But S.F. lacks the ability to understand how to minimize these
    side effects because he does not believe that he has a mental
    disorder. This also prevents him from rationally weighing the
    benefits of the medications he is prescribed.
    Dr. Fennell concluded that S.F. requires treatment with
    antipsychotic medications, is incompetent to refuse them, and
    should continue to be administered the medications
    involuntarily. The trial court agreed, and granted the
    Department’s petition to involuntarily medicate him for up to one
    year.
    DISCUSSION
    S.F. contends the involuntary medication order should be
    vacated because there was insufficient evidence that he is
    incapable of making decisions about his medical treatment. We
    disagree.
    A court may order an OMHD to be involuntarily treated
    with antipsychotic medication if it determines that the offender is
    “incompetent to refuse medical treatment.” (Qawi, supra, 32
    Cal.4th at p. 27.) Determining whether an OMHD is incompetent
    3
    to refuse treatment requires consideration of three factors: (1)
    whether the offender is aware of and acknowledges their mental
    disorder; (2) whether the offender is “able to understand the
    benefits and the risks of, as well as the alternatives to, the
    proposed intervention”; and (3) whether the offender is “able to
    understand and . . . evaluate the information required to be given
    patients whose informed consent is sought . . . and otherwise
    participate in the treatment decision by means of rational
    thought processes.” (Riese v. St. Mary’s Hospital & Medical
    Center (1987) 
    209 Cal.App.3d 1303
    , 1322-1323 (Riese).) We
    review a determination that an offender is incompetent to refuse
    medical treatment for substantial evidence. (People v. Fisher
    (2009) 
    172 Cal.App.4th 1006
    , 1016.)
    Substantial evidence supports the determination that S.F.
    is incompetent to refuse medical treatment. Dr. Fennell testified
    that S.F. suffers from schizoaffective disorder, with symptoms
    including auditory hallucinations, paranoia, irritation and
    agitation, and the belief that others wish to harm him. He also
    said that S.F. refuses to acknowledge his mental disorder, and
    instead believes that he is telepathic and does not need
    medication. S.F. did not counter Dr. Fennell’s testimony at the
    Qawi hearing, but argued his awareness that he has the “gift” of
    being able to hear voices means that he has the capacity to refuse
    treatment. The first Riese factor weighs in favor of the trial
    court’s medication order.
    So do the second and third. Because he refuses to accept
    that he suffers from a mental disorder, S.F. does not understand
    the risks and benefits of his medications. He believes his
    medications “ha[ve] literally nothing to do with” any
    improvements in his condition, “denies strongly that there are
    4
    any benefits associated” with them, and instead believes they
    only cause him harm. S.F.’s refusal to acknowledge his disorder
    also hinders his ability to discuss alternatives to his medication
    regimen, including adjusting his current dosages to help mitigate
    some of the side effects. It thus prevents him from being able to
    rationally evaluate and participate in his treatment decisions.
    The second and third Riese factors weigh in favor of the trial
    court’s medication order.
    This case is unlike Conservatorship of Waltz (1986) 
    180 Cal.App.3d 722
    , on which S.F. relies. The conservatee in Waltz
    feared undergoing electroshock treatment during his psychotic
    episodes. (Id. at p. 732.) But he also feared undergoing the
    treatment during his nonpsychotic episodes. (Ibid.) He
    additionally acknowledged he had a mental disorder, understood
    that he was undergoing treatment, understood that his doctors
    believed the treatment was helping him, understood the potential
    risks of that treatment, and understood that he could refuse it.
    (Ibid.) These understandings undercut the trial court’s
    determination that the conservatee could not give informed
    consent. (Id. at p. 734.)
    In contrast to the Waltz conservatee, here, the evidence
    does not show that S.F. has nonpsychotic episodes during which
    he understands that he has a mental disorder and the treatments
    he is undergoing. To the contrary, S.F. consistently refuses to
    acknowledge his mental disorder. He does not understand the
    risks and benefits of his medications, and cannot participate in
    his treatment decisions. Substantial evidence thus supports the
    trial court’s determination that he lacks the capacity to refuse
    medical treatments.
    5
    DISPOSITION
    The trial court’s order compelling S.F.’s involuntary
    treatment with antipsychotic medication, entered January 21,
    2022, is affirmed.
    NOT TO BE PUBLISHED.
    GILBERT, P. J.
    We concur:
    YEGAN, J.
    PERREN, J.
    6
    Michael L. Duffy, Judge
    Superior Court County of San Luis Obispo
    ______________________________
    Gerald J. Miller, under appointment by the Court of
    Appeal, for Defendant and Appellant.
    Rob Bonta, Attorney General, Cheryl L. Feiner, Assistant
    Attorney General, Gregory D. Brown and Jordan R. Beres,
    Deputy Attorneys General, for Plaintiff and Respondent.
    

Document Info

Docket Number: B317820

Filed Date: 7/26/2022

Precedential Status: Non-Precedential

Modified Date: 7/26/2022